Delfi Diagnostics Stock
DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
Sign up for SecondMarket™ to view the market and buy or sell Delfi Diagnostics Stock
Buy + SellSee Delfi Diagnostics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Delfi Diagnostics Stock Valuation + Share Prices
View real-time Tape D™ data on Delfi Diagnostics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Delfi Diagnostics Management Team
CTO
Amoolya Singh
Director
Jacob S. Van Naarden
Chief Medical Officer
Peter Bach
Co-founder, Head of Data Science
Rob Scharpf
Director
Rishi Gupta
Director
Liz Homans
CFO
Tom Russo
Founder, Director
Victor Velculescu
Director
Grep Yap
Co-founder, Chief Scientific Officer
Nicholas Dracopoli
Director
Justin Kao
CEO
Susan Tousi
Director
Mike Dybbs
Delfi Diagnostics Major Investors
Windham Venture Partners
Samsara BioCapital
AV8 Ventures
Point Field Partners
Point72 Ventures, LLC
OrbiMed Advisors LLC
DFJ Growth
Eli Lilly & Company
Cowen Healthcare Investments
Illumina, Inc.
Point72 Ventures, LLC
Menlo Ventures
Open Field Capital LLC
Foresite Capital
Learn More About Delfi Diagnostics Stock
Buy Delfi Diagnostics Stock
01Delfi Diagnostics stock does not trade on public stock exchanges. Delfi Diagnostics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Delfi Diagnostics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Delfi Diagnostics Stock
02Delfi Diagnostics Stock does not trade on public stock exchanges. In order to sell Delfi Diagnostics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Delfi Diagnostics Stock Price
03Delfi Diagnostics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Delfi Diagnostics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Delfi Diagnostics Stock Ticker Symbol
04There is no ticker symbol for Delfi Diagnostics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Delfi Diagnostics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Delfi Diagnostics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Delfi Diagnostics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Delfi Diagnostics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Delfi Diagnostics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Delfi Diagnostics IPO
08Delfi Diagnostics is a private company and has not had an IPO. There is currently no Delfi Diagnostics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Delfi Diagnostics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Delfi Diagnostics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
